JEAN JACQUES BIENAIME Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of JEAN JACQUES BIENAIME for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2017 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 133.67 | 108 | 14,436 | 1,177 | 1.1 K to 1.2 K (+10.10 %) |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 87.42 | 144,050 | 12,592,851 | 144,050 | |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 44,520 | 0 | 235,194 | 190.7 K to 235.2 K (+23.35 %) |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 57,423 | |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 62,423 | |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.96 | 5,000 | 459,800 | 190,674 | 195.7 K to 190.7 K (-2.56 %) |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 71.33 | 5,000 | 356,650 | 195,674 | 190.7 K to 195.7 K (+2.62 %) |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 92.50 | 15,690 | 1,451,325 | 190,674 | 206.4 K to 190.7 K (-7.60 %) |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.42 | 5,000 | 457,100 | 206,364 | 211.4 K to 206.4 K (-2.37 %) |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 211,364 | 206.4 K to 211.4 K (+2.42 %) |
| Mar 15 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 67,423 | |
| Mar 15 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.68 | 5,000 | 463,400 | 206,364 | 211.4 K to 206.4 K (-2.37 %) |
| Mar 15 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 211,364 | 206.4 K to 211.4 K (+2.42 %) |
| Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 72,423 | |
| Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 6,000 | 103,980 | 77,423 | |
| Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.09 | 5,000 | 455,450 | 206,364 | 211.4 K to 206.4 K (-2.37 %) |
| Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 211,364 | 206.4 K to 211.4 K (+2.42 %) |
| Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.18 | 6,000 | 541,080 | 206,364 | 212.4 K to 206.4 K (-2.83 %) |
| Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 6,000 | 103,980 | 212,364 | 206.4 K to 212.4 K (+2.91 %) |
| Mar 07 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 93.95 | 8,989 | 844,517 | 206,364 | 215.4 K to 206.4 K (-4.17 %) |